SMS Pharmaceuticals informs about press release

26 Nov 2025 Evaluate
SMS Pharmaceuticals has informed that it enclosed the press release titled ‘SMS Pharmaceutical’s Associate Company, VKT Pharma, receives US FDA approval for its reformulated Ranitidine’. The above information will also be made available on the website of the Company at www.smspharma.com.

The above information is a part of company’s filings submitted to BSE.

SMS Pharmaceuticals Share Price

302.85 4.50 (1.51%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×